Fifth Third Bancorp Vanda Pharmaceuticals Inc. Transaction History

Fifth Third Bancorp

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Oct 31, 2023	SELL	$4.28 - $6.57 $577 - $886	-135 Reduced 72.19%	52 $0
Q2 2023 Jul 25, 2023	SELL	$5.9 - $6.95 $1,663 - $1,959	-282 Reduced 60.13%	187 $1,000
Q1 2023 Apr 24, 2023	BUY	$6.18 - $7.99 $2,206 - $2,852	357 Added 318.75%	469 $3,000
Q4 2022 Jan 25, 2023	BUY	$6.87 - $10.96 $769 - $1,227	112 New	112 $0
Q1 2022 Apr 19, 2022	SELL	$10.84 - $16.55 $3,902 - $5,958	-360 Closed	0 $0
Q4 2021 Feb 01, 2022	BUY	$15.69 - $21.14 $3,859 - $5,200	246 Added 215.79%	360 $6,000
Q3 2021 Oct 15, 2021	BUY	$15.35 - $21.27 $1,749 - $2,424	114 New	114 $2,000

161

45.2M

165K

33.6K

Ticker VNDA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 56,561,500
Market Cap $274M
Description
Vanda Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of therapies to address high unmet medical needs. The company's marketed products include HETLIOZ for the treatment of non-24-hour sleep-wake disorders; and Fanapt oral tablets for the treatment of schizophrenia. Its products under developme...

Get notified when there are updates to the investment portfolio of Fifth Third Bancorp, based on Form 13F filings with the SEC.

Stay updated on Fifth Third Bancorp with notifications on news.